25 Jun MetaGene partners with Rare Cancers Australia
Today, we announce that MetaGene partners with Rare Cancers Australia. Richard Holder CEO of MetaGene announced that the company has partnered with Rare Cancers Australia (RCA) to be the charity of choice. “The support of our customers during our Ducks in a Row Campaign at DIHC 2018 helped raise $1,200 for RCA to help with their fantastic work.”
“Rare Cancers Australia Ltd (RCA) is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common (RLC) cancers. In Australia in 2017, an estimated 52,000 people will be diagnosed with a RLC cancer and 25,000 will die from them, according to Cancer in Australia 2017 estimates”.